Stay updated on Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.
    Difference
    0.2%
    Check dated 2025-01-12T20:46:16.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T23:04:45.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.
    Difference
    2%
    Check dated 2024-12-07T17:23:24.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The website has added a 'Show less' feature while removing extensive details about participant groups, interventions, and various data fields available for download.
    Difference
    3%
    Check dated 2024-11-23T05:13:39.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Several links to health-related resources, including Dailymed and government health sites, have been removed.
    Difference
    0.2%
    Check dated 2024-11-16T00:39:42.000Z thumbnail image
  9. Check
    68 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding new links for drug information and various data fields for study details, while removing the option to show less content.
    Difference
    3%
    Check dated 2024-11-08T18:49:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.